For the Inventor, By the Inventor

Enter assignee name

Bridgewater, NJ, United States of America

Merrell Pharmaceuticals, Inc.

USPTO Granted Patents = 194

% Expired Patents = 1.5

CIPO Patents = 122

Trademarks = 8

Forward Citations = 893

Loading Chart...

Loading Chart...

173 inventors (with patents filed for the assignee):

Albert A Carr (30 out of 77 patents)

David A Hay (19 out of 22 patents)

Norton P Peet (15 out of 87 patents)

4. Gary A Flynn (15 out of 81 patents)

5. Daniel G Schirlin (14 out of 16 patents)

6. Alan D Cardin (13 out of 26 patents)

7. Richard A Wolf (13 out of 24 patents)

8. Duane E Rudisill (13 out of 14 patents)

9. Gianbattista Panzone (12 out of 25 patents)

10. Robert M Strom (12 out of 34 patents)

11. Carey L Scortichini (12 out of 23 patents)

12. Richard C Krauss (12 out of 20 patents)

13. John M Kane (12 out of 49 patents)

14. Joseph P Burkhart (12 out of 33 patents)

15. Weishi W Wu (12 out of 34 patents)

Core Competencies:

Antihistaminic Derivatives

Elastase Inhibitors

Antiviral Agents

Peptidase Inhibitors

Polyamine Derivatives

Cytokine Inhibitors

Neurokinin Antagonists

Xanthine Derivatives

Steroid Inhibitors

Antidepressants

Anticoagulant Peptides

Anti-HIV Compounds

194 patents: Sort by Forward Citations

1. 6777555 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2004-08-17),

2. 6566526 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2003-05-20),

3. 6559312 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2003-05-06),

4. 6555689 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2003-04-29),

5. 6552200 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2003-04-22),

6. 6548675 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2003-04-15),

7. 6479663 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2002-11-12),

8. 6441179 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2002-08-27),

9. 6420373 - 9-N-Bicyclic nuceoside agents useful as selective inhibitors of proinflammatory cytokines (2002-07-16),

10. 6399632 - Method of providing an antihistaminic effect in a hepatically impaired patient (2002-06-04),

11. 6348597 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2002-02-19),

12. 6340761 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2002-01-22),

13. 6313161 - 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, 19-hydroxylase inhibitors and methods of their use in the treatment of estrogen mediated disorders (2001-11-06),

14. 6265381 - Orally-active elastase inhibitors (2001-07-24),

15. 6242606 - Intermediates useful for the preparation of antihistaminic piperidine derivatives (2001-06-05),

Merrell Pharmaceuticals, Inc. is a leading global pharmaceutical company dedicated to improving the lives of people around the world. With a commitment to innovation, we develop and commercialize high-quality therapeutics in areas such as oncology, infectious diseases, and cardiovascular health. Our extensive product portfolio includes both prescription medicines and over-the-counter drugs, providing a comprehensive range of solutions for various healthcare needs. At Merrell Pharmaceuticals, we prioritize patient care and strive for excellence in everything we do.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

194 Patents

#3 in Bridgewater, NJ

#96 in New Jersey

#2,122 in US

#4,335 in the World

Bridgewater, NJ, United States of America

Merrell Pharmaceuticals, Inc.

Forward Citations = 893

173 inventors:

Albert A Carr (30 out of 77 patents)

David A Hay (19 out of 22 patents)

Norton P Peet (15 out of 87 patents)

4. Gary A Flynn (15 out of 81 patents)

5. Daniel G Schirlin (14 out of 16 patents)

Please report any incorrect information to [email protected]

Loading…